posted
What completely blew me away in pre-market trading was how easily it went over $6. I didn't buy it because it opened at 3.75 from a previous close of $1.97. That was an 85% opening. There's no way I was gonna buy it so high but then I saw it rocketed to 230% ($6 something) by 9am and I felt like such a jacka$$.
I could have made sooo much more money today. Hell I coulda made close to a double on $5K.
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
quote:Originally posted by Lootcifer: What completely blew me away in pre-market trading was how easily it went over $6. I didn't buy it because it opened at 3.75 from a previous close of $1.97. That was an 85% opening. There's no way I was gonna buy it so high but then I saw it rocketed to 230% ($6 something) by 9am and I felt like such a jacka$$.
I could have made sooo much more money today. Hell I coulda made close to a double on $5K.
WHAT!!!!!!!? No way
This hit $6 this morning?? Ch1t, thats what I get for selling so hastily, plus waking up late this morning. That would have been over a 300% gain for me today. Now I feel like Jo4321 that sold too early.
-------------------- One risk I enjoy: daytrading stocks Posts: 273 | From: New York City | Registered: Sep 2004
| IP: Logged |
quote:Originally posted by Lootcifer: What completely blew me away in pre-market trading was how easily it went over $6. I didn't buy it because it opened at 3.75 from a previous close of $1.97. That was an 85% opening. There's no way I was gonna buy it so high but then I saw it rocketed to 230% ($6 something) by 9am and I felt like such a jacka$$.
I could have made sooo much more money today. Hell I coulda made close to a double on $5K.
WHAT!!!!!!!? No way
This hit $6 this morning?? Ch1t, thats what I get for selling so hastily, plus waking up late this morning. That would have been over a 300% gain for me today. Now I feel like Jo4321 that sold too early.
Yeah thats right. I was watching it and commenting with Repo as it rocketed. Within the first hour alone, volume had skyrocketed to over 3 million shares. That was 12 times the average daily. Now look at it.
Its at 36 million shares now. Thats 159 times the average daily volume. What does that tell you about this stock between tomorrow and the coming days. Look for a flood of PRs IMO.
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
quote:Jo, you are just fighting a losing battle with yourself, aren't you? Sorry to hear that...!
Yeah, I'm thinking of starting a thread where I tell you folks when I sell something, so you all can get in
I'm also watching ACTC which I sold last week at .65 now going up to .83
Of course, the ones I hold go down (PBLS, RKLC)
I almost wasn't going to post here that I sold SIGA yesterday cause I didn't think anyone would believe someone could be such a bad trader. But sadly, it is true. I did make 60 bucks or so on it! (vice $3500 if I would have sold at $5.50). Guess I'll just say that a little profit is better than none, and move on.
Definitely won't mention this one to hubby.
Jo
-------------------- "Great Day for Up!"....Dr. Seuss Posts: 3387 | Registered: Mar 2006
| IP: Logged |
quote:Jo, you are just fighting a losing battle with yourself, aren't you? Sorry to hear that...!
Yeah, I'm thinking of starting a thread where I tell you folks when I sell something, so you all can get in
I'm also watching ACTC which I sold last week at .65 now going up to .83
Of course, the ones I hold go down (PBLS, RKLC)
I almost wasn't going to post here that I sold SIGA yesterday cause I didn't think anyone would believe someone could be such a bad trader. But sadly, it is true. I did make 60 bucks or so on it! (vice $3500 if I would have sold at $5.50). Guess I'll just say that a little profit is better than none, and move on.
Definitely won't mention this one to hubby.
Jo
Don't feel bad Jo, I did the same thing. You made a decision and stuck by it. Warren Buffet says a profit is a profit. Its better you made 60 bucks than lost 500.
-------------------- One risk I enjoy: daytrading stocks Posts: 273 | From: New York City | Registered: Sep 2004
| IP: Logged |
posted
Whats gonna suck is watching it go even higher like ACOR and I'll just have to sit back and shake my head in amazement and wonder what coulda happened to my portfolio.
I tell you one thing, a lot of my bills would have gotten paid nicely this week.
-------------------- One risk I enjoy: daytrading stocks Posts: 273 | From: New York City | Registered: Sep 2004
| IP: Logged |
posted
I sold 75% of my CSHD holdings at 3.90 and never looked back. I saw that you sold day before yesterday Jo. I don't blame you on that one either. The way Rufus put out the 10K and other news was just too messy. Honestly I have no more confidence in CSHD. Just riding the other 25% of my free shares to see what happens.
But anyway this is SIGA let me stick to the subject
-------------------- One risk I enjoy: daytrading stocks Posts: 273 | From: New York City | Registered: Sep 2004
| IP: Logged |
posted
I know I shouldn't do this, but based on the possibilities of the next few days. I think this will see $8. The volatility speaks for itself right now.
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
posted
I know this is off topic, but I here's someone with worse luck than me.
--------------------------
U.S. casino magnate gives Picasso's dream the elbow Wed Oct 18, 9:43 AM ET
LOS ANGELES (Reuters) - Picasso's famed "Dream" painting turned into a nightmare for Las Vegas casino magnate Steve Wynn when he accidentally gave the multimillion dollar canvas an elbow.
Wynn had just finalized a $139 million sale to another collector of his painting, called "Le Reve" (The Dream), when he poked a finger-sized hole in the artwork while showing it to friends at his Las Vegas office a couple of weeks ago.
Director and screenwriter Nora Ephron, who witnessed and related the incident in her **** on the Huffington Post Web site (www.huffingtonpost.com), said Wynn had raised his hand to show the group something about Picasso's 1932 portrait of his mistress Marie-Therese Walter.
"At that moment, his elbow crashed backward right through the canvas. There was a terrible noise," Ephron wrote, noting that Wynn has retinitis pigmentosa, an eye disease that damages peripheral vision.
"Smack in the middle ... was a black hole the size of a silver dollar. 'Oh s---,' he said. 'Look what I've done. Thank goodness it was me.'"
Wynn's office on Tuesday confirmed the story, an account of which also appeared in this week's The New Yorker. Both accounts said Wynn had decided to release the buyer from the sale agreement and to repair and keep the painting himself.
Wynn, a millionaire casino developer and art collector, developed The Mirage and Bellagio resorts in Las Vegas in the 1990s, which spearheaded a profusion of luxury hotels and casinos on the once-seedy Las Vegas Strip.
-------------------- "Great Day for Up!"....Dr. Seuss Posts: 3387 | Registered: Mar 2006
| IP: Logged |
posted
Wow, I wouldn't wanna be that guy right now. He better have a brass pair, cause thats gotta hurt. Can you imagine the amount of money he lost with that elbow to the painting??
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
quote:Jo, you are just fighting a losing battle with yourself, aren't you? Sorry to hear that...!
Yeah, I'm thinking of starting a thread where I tell you folks when I sell something, so you all can get in
I'm also watching ACTC which I sold last week at .65 now going up to .83
Of course, the ones I hold go down (PBLS, RKLC)
I almost wasn't going to post here that I sold SIGA yesterday cause I didn't think anyone would believe someone could be such a bad trader. But sadly, it is true. I did make 60 bucks or so on it! (vice $3500 if I would have sold at $5.50). Guess I'll just say that a little profit is better than none, and move on.
Definitely won't mention this one to hubby.
Jo
Don't feel bad Jo, I did the same thing. You made a decision and stuck by it. Warren Buffet says a profit is a profit. Its better you made 60 bucks than lost 500.
Agreed. I've heard "shoulda coulda woulda" a lot. If you just make safe trades for $60 a day, you won't care about the ones you missed in a while....
-------------------- Study before you buy, Sell before you think about it.... Posts: 3903 | From: Gulf Coast | Registered: Jun 2006
| IP: Logged |
posted
whew, I was getting worried because I had bought in on this stock awhile ago * 2.20. =)
Posts: 51 | From: Tampa, FL | Registered: Sep 2006
| IP: Logged |
quote:Originally posted by Stockstar69: Another day! Wonder what today will bring? Will we go back down to where we were last week or are we running now with the big news?
Anyone see any chance of a buyout by another big pharma?
I don't see that happening. In their previous PR they ended the merger with PharmaThene because they claim to have enough funding to sustain themselves. And obviously they had these results for smallpox but just wasn't ready to drop the news til yesterday.
I expect them to get an enormous amount of extra funding from other sources. JMO
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
quote:Originally posted by invester: Just picked up 1000 at $4.29 pre market.
I think you shoulda waited Investor. They tend to move it up in pre-market and tank it at opening bell. But you might get lucky since today is Friday aka selloff day. So they just might raise it a little over $4.30 and dump for the weekend.
Good Luck though
-------------------- Best Regards and Good Trading Posts: 239 | From: Florida City, FL | Registered: Jul 2006
| IP: Logged |
quote:Originally posted by invester: Just picked up 1000 at $4.29 pre market.
I think you shoulda waited Investor. They tend to move it up in pre-market and tank it at opening bell. But you might get lucky since today is Friday aka selloff day. So they just might raise it a little over $4.30 and dump for the weekend.
Good Luck though
]
It had a major sell off yesterday. The market cap is only $115m. I think it goes higher today. "I hope" Posts: 4381 | From: houston | Registered: Mar 2006
| IP: Logged |
"Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec"
wouldn't you do this? anyone surprised? I would think they would let the pps grow a bit.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
posted
With an infusion of 240 million in govt grants in the last 2 1/2 months it seems odd especially at this time!
-------------------- " A man's got to know his limitations." Clint Eastwood in Magnum Force Posts: 179 | From: Virginia Beach , Va | Registered: Oct 2006
| IP: Logged |
posted
odd that insiders would take some profit so early??? freekin newBs LMAO.
oh wait I am 1! Was not in this but sure woulda been nice.
-------------------- All post are my opinion. Do your own DD. Who's clicking your buy/sell button!? Posts: 7800 | From: Virginia | Registered: May 2006
| IP: Logged |
At Siga Technologies’ Corvallis research labs, Eric Stavale works on a possible treatment for the Dengue virus. Siga got a big cash infusion last week after announcing progress on an experimental smallpox treatment.
Siga Technologies finds quick payoff from test of smallpox remedy
By BENNETT HALL Gazette-Times business editor
It’s been a long and bumpy road, but the finish line may be in sight for Siga Technologies in its journey toward profitability.
Like many — if not most — small drug-discovery companies, Siga has burned through millions of dollars and posted year after year of losses as it tried to bring a developmental treatment to market. After a successful animal trial announced last week, however, the company could be on the verge of scoring a major coup with the first effective treatment for smallpox.
“In the biodefense area, smallpox is the number one concern, and we would expect this is going to be our big product,” said Dennis Hruby, Siga’s chief scientific officer and a microbiology professor at Oregon State University.
Smallpox was eradicated in nature 30 years ago but is considered a potential terrorist threat, and no proven treatment for the deadly virus exists. The Defense Department and other federal agencies funded the latest test, conducted on monkeys at a secure Centers for Disease Control facility in Atlanta.
Siga claims its drug, a once-daily pill called Siga-246, showed “100 percent protection” against the smallpox virus, both before and after exposure. The drug previously passed a human safety trial.
Additional tests are needed before the company can request approval from the Food & Drug Administration, but the Defense Department is footing the bill with a $16.5 million grant.
The news of a successful test triggered a financial windfall for Siga, which employs 50 people at its Corvallis research labs.
On Wednesday, the day the test results were announced, the company’s stock price more than doubled, shooting up to $4.54 a share after languishing at around $1 for most of the last year.
On Thursday, the company completed a $9 million private stock placement with some of its longtime institutional investors. Five hedge funds — Iroquois Master Fund, Cranshire Capital, Omicron Master Trust, Rockmore Investment Master Fund and Smithfield Fiduciary — bought the issue, consisting of 2 million shares of common stock at $4.54 a share. They also received warrants for an additional 1 million shares exercisable at $4.99 a share.
“It gave us the opportunity to bring in some cash quickly at a nice price,” said chief financial officer and acting CEO Tom Konatich, who’s been with the biotech firm for eight years. “Our balance sheet right now is about as strong as it’s been during my tenure.”
The stock placement caps a resurgence for Siga, which had entered a merger agreement last spring with an East Coast biotech company and faced delisting from the Nasdaq exchange this summer as its market capitalization slipped.
Now, with its cash reserves recharged and a smallpox drug marching toward approval, the merger is off and Siga is on the rebound.
“Siga’s a significantly different company today than it was in February and March,” Konatich said by phone from the company’s New York headquarters Friday. “We will be lobbying and negotiating with various agencies of the federal government for a sale of the drug.”
Konatich declined to speculate on when a deal to supply the drug might be reached or what it might be worth to Siga. But he did say that various industry estimates make it clear that the potential market for smallpox treatments is a lucrative one.
“It’s in the hundreds of millions of dollars, if not more,” he said.
Other potential markets await overseas, particularly in Europe. Hruby has been invited to Geneva to make a presentation to the World Health Organization’s advisory council, which he hopes will help spread the word about Siga’s research.
Hruby said Siga-246 can treat monkeypox and related viral diseases, and the firm is also pursuing drug candidates for a range of other exotic viruses.
“There’s two things: There’s biodefense, and there’s emerging diseases,” Hruby said. “Hopefully, we’ll never need it for biodefense. But it’s nice to have a drug like this on the shelf.”
Bennett Hall is the business editor for the Gazette-Times. He can be reached at 758-9529 or bennett.hall*lee.net.
-------------------- "Great Day for Up!"....Dr. Seuss Posts: 3387 | Registered: Mar 2006
| IP: Logged |
posted
Biotech News: Analysis of SIGA Technologies Inc Nice news: Up nearly 12% ($3.75)
11:07a ET November 7, 2006 (Comtex) Analysis of SIGA Technologies Inc (NASDAQ: SIGA)
Say "ahhh" instead of "ow!" If development-stage SIGA Technologies has its way, painful vaccinations could become a thing of the past. The company is working on technology to administer vaccines directly through the mucus-lined surfaces -- mouth, nose, lungs, and gastrointestinal and urogenital tracts -- that are the usual entry points for most infectious agents. It focuses on vaccines, novel anti-infectives, and antibiotics for infectious diseases; its lead candidates are vaccines for bio-defense. In 2006 SIGA made breakthrough progress on a smallpox treatment, which completely prevented the disease in preliminary primate trials. The advancement led to funding from the National Institutes of Health.
Shares were up 10% after leading drug was shown to be successful.
BellwetherReport.com is a leading online research firm for international investors looking to get an edge over their portfolio. Investors seeking the most up to date information on SIGA Technologies Inc are invited to sign up for a free complimentary subscription to www.bellwetherreport.com. No credit card needed!
It was Siga Technologies Inc.'s turn to shine Wednesday, as shares jumped on news that the biotechnology company's leading drug was shown to be successful in protecting against smallpox, considered a bioterror threat.
Siga said SIGA-246 prevented symptoms when administered at the same time as the virus and 24 hours after exposure of the virus, in a government-funded study on monkeys.
Shares leapt $2.57, more than doubling in price, to close at $4.54 Wednesday on the Nasdaq. Heavy trading reached a volume of 39.3 million shares, more than 40 times the stock's average.
On Thursday, Siga announced it would sell 2 million shares for $4.54 per share, for a total of about $9 million, plus an additional 1 million warrants.
The stock continued to trade heavily and remained above $4 until Friday afternoon, ending the week at $3.92.
More information on SIGA Technologies Inc available in the members section of www.BellwetherReport.com.
To review research on SIGA Technologies Inc as well as many more exciting articles we encourage you to visit www.bellwetherreport.com. You can find these reports under the "Today's Articles" section. No credit Card Needed!!
The Bellwether Report will continue to research the small cap markets to bring you exciting opportunities!! If you are interested in receiving more information on these small cap opportunities and other features of our site, feel free to sign up for a complimentary subscription to the #1 online investment tool www.bellwetherreport.com.
Companies looking to advertise with Bellwether Report should email jlee*bellwetherreport.com with the subject line (Advertising).
All material herein was prepared by the Bellwetherreport.com, (Bellwether) based upon information believed to be reliable. The information contained herein is not guaranteed by Bellwether to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bellwether is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Bellwether may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Bellwether's affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value.
Bellwether will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bellwether undertakes no obligation to update such statements.
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info*m2.com.
-------------------- "Great Day for Up!"....Dr. Seuss Posts: 3387 | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
![[Eek!]](eek.gif)
![[Big Grin]](biggrin.gif)
![[Mad]](mad.gif)
![[Wink]](wink.gif)
![[Frown]](frown.gif)
![[Cool]](cool.gif)
![[Smile]](smile.gif)
